Skip to content

Acupressure for Pain and Opioid Use Among Breast Cancer Patients

TerminatedNot applicableNCT03655600
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study seeks to determine the feasibility of recruiting and training participants in self-acupressure, for women undergoing primary breast cancer surgery or delayed reconstruction surgery. The study seeks to determine also if self-acupressure is effective in reducing the need for opioids post-surgery and the effects on other life factors.

Study details

Official title
Acupressure for Preventing Post-Operative Pain and Opioid Use Among Breast Cancer Patients Receiving Surgery
Interventions
  • Other: Self-administered acupressure
Sponsor
University of Michigan
Collaborators
Substance Abuse and Mental Health Services Administration (SAMHSA); Michigan Opioid Prescribing Engagement Network (Michigan-OPEN)
Start date
2018-09-17
Primary completion
2019-10-17
Sex
Female
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Diagnosis of breast cancer stage 0 to III; 2. Planned unilateral or bilateral mastectomy or planned delayed breast reconstruction surgery within 24 months following unilateral or bilateral mastectomy; 3. For delayed breast reconstruction patients only: apparently cancer free at time of delayed reconstruction; 4. No planned new interventions for pain the two weeks prior to surgery; 5. Able to self-administer treatment at the specified points. Exclusion Criteria: 1. Medically unstable (e.g. uncontrolled diabetes, high blood pressure, etc.); 2. For delayed breast reconstruction only: taking aromatase inhibitors which could confound surgical and chronic pain measurements; 3. Have a diagnosis of untreated mood disorder, e.g., bipolar or major depressive disorder; 4. Unwilling to maintain stable does of allowed chronic pain medications (e.g. NSAIDS, benzodiazepines, SSRIs and SNRIs); 5. Pregnant, those planning a pregnancy, or lactating mothers; 6. Any medical condition or treatment factor that the study team feels would either compromise the data acquired or introduce a potential safety concern. 7. Unable to give consent; 8. Acupuncture or acupressure receipt in past year

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03655600